Transcriptomics,Multiomics

Dataset Information

6

Transcription profiling of human samples of bone morrow or peripheral blood mononuclear cells from adult patients with untreated acute myeloid leukemia to develop a prognostic gene signature for normal karyotype AML


ABSTRACT: Patients with cytogenetically normal acute myeloid leukemia (CN-AML) show heterogeneous treatment outcomes. We used gene expression profiling to develop a gene signature that predicts overall survival (OS) in CN-AML. Based on data from 163 patients treated in the German AMLCG 1999 trial and analyzed on oligonucleotide microarrays, we used supervised principal component analysis to identify 86 probe sets (representing 66 different genes) which correlated with OS, and defined a prognostic score based on this signature. When applied to an independent cohort of 79 CN-AML patients, this continuous score remained a significant predictor for OS (hazard ratio [HR], 1.85; P=0.002), EFS (HR, 1.73; P=0.001), and RFS (HR, 1.76; P=0.025). It kept its prognostic value in multivariate analyses adjusting for age, FLT3 ITD and NPM1 status. In a validation cohort of 64 CN-AML patients treated on CALGB study 9621, the score also predicted OS (HR, 4.11; P<0.001), EFS (HR, 2.90; P<0.001), and RFS (HR, 3.14, P<0.001) and retained its significance in a multivariate model for OS. In summary, we present a novel gene expression signature that offers additional prognostic information for patients with CN-AML. Experiment Overall Design: Analysis of 163 samples of bone morrow or peripheral blood mononuclear cells from adult patients with untreated acute myeloid leukemia

OTHER RELATED OMICS DATASETS IN: PRJNA113111

INSTRUMENT(S): 418 [Affymetrix]

SUBMITTER: Klaus H. Metzeler  

PROVIDER: E-GEOD-12417 | ArrayExpress | 2008-10-26

SECONDARY ACCESSION(S): GSE12417PRJNA113111

REPOSITORIES: GEO, ArrayExpress

Dataset's files

Source:
Action DRS
E-GEOD-12417.README.txt Txt
E-GEOD-12417.eSet.r Other
E-GEOD-12417.idf.txt Idf
E-GEOD-12417.processed.1.zip Processed
E-GEOD-12417.raw.1.zip Raw
Items per page:
1 - 5 of 13
altmetric image

Publications


Patients with cytogenetically normal acute myeloid leukemia (CN-AML) show heterogeneous treatment outcomes. We used gene-expression profiling to develop a gene signature that predicts overall survival (OS) in CN-AML. Based on data from 163 patients treated in the German AMLCG 1999 trial and analyzed on oligonucleotide microarrays, we used supervised principal component analysis to identify 86 probe sets (representing 66 different genes), which correlated with OS, and defined a prognostic score b  ...[more]

Similar Datasets

2008-08-22 | GSE12417 | GEO
2016-01-01 | S-EPMC4863771 | BioStudies
2019-01-01 | S-EPMC6485112 | BioStudies
2008-01-01 | S-EPMC2954679 | BioStudies
1000-01-01 | S-EPMC4061003 | BioStudies
2020-01-01 | S-EPMC7139772 | BioStudies
2019-01-01 | S-EPMC6528257 | BioStudies
2014-01-01 | S-EPMC3885535 | BioStudies
2014-01-01 | S-EPMC4284555 | BioStudies
2020-01-01 | S-EPMC7371194 | BioStudies